A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.
Identifieur interne : 003808 ( PubMed/Curation ); précédent : 003807; suivant : 003809A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.
Auteurs : J. Stokkermans-Dubois [France] ; T. Jouary ; B. Vergier ; M M Delaunay ; A. TaiebSource :
- Dermatology (Basel, Switzerland) [ 1018-8665 ] ; 2006.
Descripteurs français
- KwdFr :
- Antigènes CD45 (analyse), Antigènes CD56 (analyse), Cellules tueuses naturelles (anatomopathologie), Humains, Jambe, Lymphoedème (diagnostic), Lymphome T cutané (anatomopathologie), Lymphome T cutané (diagnostic), Mâle, Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Sujet âgé, Tumeurs cutanées (anatomopathologie), Tumeurs cutanées (diagnostic), Études de suivi.
- MESH :
- analyse : Antigènes CD45, Antigènes CD56.
- anatomopathologie : Cellules tueuses naturelles, Lymphome T cutané, Tumeurs cutanées.
- diagnostic : Lymphoedème, Lymphome T cutané, Tumeurs cutanées.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- Humains, Jambe, Mâle, Sujet âgé, Études de suivi.
English descriptors
- KwdEn :
- Aged, Antigens, CD45 (analysis), Antigens, CD56 (analysis), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Follow-Up Studies, Humans, Killer Cells, Natural (pathology), Leg, Lymphedema (diagnosis), Lymphoma, T-Cell, Cutaneous (diagnosis), Lymphoma, T-Cell, Cutaneous (pathology), Male, Skin Neoplasms (diagnosis), Skin Neoplasms (pathology).
- MESH :
- chemical , analysis : Antigens, CD45, Antigens, CD56.
- diagnosis : Lymphedema, Lymphoma, T-Cell, Cutaneous, Skin Neoplasms.
- pathology : Killer Cells, Natural, Lymphoma, T-Cell, Cutaneous, Skin Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Aged, Follow-Up Studies, Humans, Leg, Male.
Abstract
Cutaneous T-cell lymphoma subtypes are now better identified thanks to progress in immunohistochemistry. This article describes a new case of primary cutaneous natural killer/T-cell lymphoma of nasal type (NKTL-NT) and reviews 18 other cases of this rare neoplasm.
DOI: 10.1159/000096201
PubMed: 17135744
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003808
Links to Exploration step
pubmed:17135744Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.</title><author><name sortKey="Stokkermans Dubois, J" sort="Stokkermans Dubois, J" uniqKey="Stokkermans Dubois J" first="J" last="Stokkermans-Dubois">J. Stokkermans-Dubois</name><affiliation wicri:level="1"><nlm:affiliation>Skin and Cancer Unit, Department of Dermatology, Saint André Hospital, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Skin and Cancer Unit, Department of Dermatology, Saint André Hospital, Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Jouary, T" sort="Jouary, T" uniqKey="Jouary T" first="T" last="Jouary">T. Jouary</name></author><author><name sortKey="Vergier, B" sort="Vergier, B" uniqKey="Vergier B" first="B" last="Vergier">B. Vergier</name></author><author><name sortKey="Delaunay, M M" sort="Delaunay, M M" uniqKey="Delaunay M" first="M M" last="Delaunay">M M Delaunay</name></author><author><name sortKey="Taieb, A" sort="Taieb, A" uniqKey="Taieb A" first="A" last="Taieb">A. Taieb</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:17135744</idno><idno type="pmid">17135744</idno><idno type="doi">10.1159/000096201</idno><idno type="wicri:Area/PubMed/Corpus">003808</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003808</idno><idno type="wicri:Area/PubMed/Curation">003808</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003808</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.</title><author><name sortKey="Stokkermans Dubois, J" sort="Stokkermans Dubois, J" uniqKey="Stokkermans Dubois J" first="J" last="Stokkermans-Dubois">J. Stokkermans-Dubois</name><affiliation wicri:level="1"><nlm:affiliation>Skin and Cancer Unit, Department of Dermatology, Saint André Hospital, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Skin and Cancer Unit, Department of Dermatology, Saint André Hospital, Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Jouary, T" sort="Jouary, T" uniqKey="Jouary T" first="T" last="Jouary">T. Jouary</name></author><author><name sortKey="Vergier, B" sort="Vergier, B" uniqKey="Vergier B" first="B" last="Vergier">B. Vergier</name></author><author><name sortKey="Delaunay, M M" sort="Delaunay, M M" uniqKey="Delaunay M" first="M M" last="Delaunay">M M Delaunay</name></author><author><name sortKey="Taieb, A" sort="Taieb, A" uniqKey="Taieb A" first="A" last="Taieb">A. Taieb</name></author></analytic><series><title level="j">Dermatology (Basel, Switzerland)</title><idno type="ISSN">1018-8665</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antigens, CD45 (analysis)</term><term>Antigens, CD56 (analysis)</term><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term><term>Follow-Up Studies</term><term>Humans</term><term>Killer Cells, Natural (pathology)</term><term>Leg</term><term>Lymphedema (diagnosis)</term><term>Lymphoma, T-Cell, Cutaneous (diagnosis)</term><term>Lymphoma, T-Cell, Cutaneous (pathology)</term><term>Male</term><term>Skin Neoplasms (diagnosis)</term><term>Skin Neoplasms (pathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antigènes CD45 (analyse)</term><term>Antigènes CD56 (analyse)</term><term>Cellules tueuses naturelles (anatomopathologie)</term><term>Humains</term><term>Jambe</term><term>Lymphoedème (diagnostic)</term><term>Lymphome T cutané (anatomopathologie)</term><term>Lymphome T cutané (diagnostic)</term><term>Mâle</term><term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term><term>Sujet âgé</term><term>Tumeurs cutanées (anatomopathologie)</term><term>Tumeurs cutanées (diagnostic)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antigens, CD45</term><term>Antigens, CD56</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Antigènes CD45</term><term>Antigènes CD56</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Cellules tueuses naturelles</term><term>Lymphome T cutané</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term><term>Lymphoma, T-Cell, Cutaneous</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term><term>Lymphome T cutané</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Killer Cells, Natural</term><term>Lymphoma, T-Cell, Cutaneous</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Follow-Up Studies</term><term>Humans</term><term>Leg</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Jambe</term><term>Mâle</term><term>Sujet âgé</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cutaneous T-cell lymphoma subtypes are now better identified thanks to progress in immunohistochemistry. This article describes a new case of primary cutaneous natural killer/T-cell lymphoma of nasal type (NKTL-NT) and reviews 18 other cases of this rare neoplasm.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17135744</PMID><DateCreated><Year>2006</Year><Month>11</Month><Day>30</Day></DateCreated><DateCompleted><Year>2007</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1018-8665</ISSN><JournalIssue CitedMedium="Print"><Volume>213</Volume><Issue>4</Issue><PubDate><Year>2006</Year></PubDate></JournalIssue><Title>Dermatology (Basel, Switzerland)</Title><ISOAbbreviation>Dermatology (Basel)</ISOAbbreviation></Journal><ArticleTitle>A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.</ArticleTitle><Pagination><MedlinePgn>345-9</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Cutaneous T-cell lymphoma subtypes are now better identified thanks to progress in immunohistochemistry. This article describes a new case of primary cutaneous natural killer/T-cell lymphoma of nasal type (NKTL-NT) and reviews 18 other cases of this rare neoplasm.</AbstractText><AbstractText Label="CASE REPORT" NlmCategory="METHODS">A 79-year-old man presented with a 3-cm nodular tumor of the left leg occurring on a primary chronic lymphedema of the legs. The lesion was CD56+, CD3 intracytoplasmic+, CD45+ and Epstein-Barr virus+. A comprehensive workup including CT scan and bone marrow biopsy was negative and a diagnosis of NKTL-NT with a primary cutaneous involvement was made. The patient was free of disease under multi-agent chemotherapy after 24 months of follow-up.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">After reviewing 18 other cases of primary cutaneous NKTL-NT, we conclude that the prognosis of these lymphomas is usually poor. However, limited cutaneous forms have a longer median survival than extracutaneous variants.</AbstractText><CopyrightInformation>Copyright (c) 2006 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stokkermans-Dubois</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Skin and Cancer Unit, Department of Dermatology, Saint André Hospital, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jouary</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Vergier</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Delaunay</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Taieb</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Dermatology</MedlineTA><NlmUniqueID>9203244</NlmUniqueID><ISSNLinking>1018-8665</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019002">Antigens, CD56</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="D017493">Antigens, CD45</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017493" MajorTopicYN="N">Antigens, CD45</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019002" MajorTopicYN="N">Antigens, CD56</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016410" MajorTopicYN="N">Lymphoma, T-Cell, Cutaneous</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>12</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>12</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>2</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>12</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17135744</ArticleId><ArticleId IdType="pii">96201</ArticleId><ArticleId IdType="doi">10.1159/000096201</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003808 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003808 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:17135744
|texte= A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:17135744" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |